Status:
RECRUITING
Precision Medicine for L/GCMN and Melanoma 1
Lead Sponsor:
Fundacion Clinic per a la Recerca Biomédica
Collaborating Sponsors:
Hospital Clinic of Barcelona
Conditions:
Melanoma (Skin Cancer)
Nevi and Melanomas
Eligibility:
All Genders
Brief Summary
The primary objective of this study is to create a highly multidimensional and multicentric database for melanoma that encompasses cohorts of children, adolescent and young adults. This database will ...
Detailed Description
Precis-Mel 1 is a unicentric observational study using retrospectively collected data. The proposed procedure is to start using data including demographic and family data, genetic data, medical proced...
Eligibility Criteria
Inclusion
- \- Melanoma patients of any age with histopathological confirmed melanoma
Exclusion
- Not having a melanoma diagnosis
- Not having signed the informed consent
- Records prior to the year 2012 (as data might not accurately reflect current practices and treatment outcomes)
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT06608420
Start Date
March 1 2024
End Date
November 30 2026
Last Update
February 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínic de Barcelona (Dermatology service)
Barcelona, Catalonia, Spain, 08036